Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs DKS✓SelectedUSD · DKSGSK vs DKS performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs DKS

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+270.5%
DKS return
+6,717.5%
Excess return
-6,447.0%
Maximum drawdown
-49.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioDKSExcessAlpha
1D-0.1%-1.8%+1.7%+0.1%
7D-1.3%-0.5%-0.9%-1.3%
30D+2.7%+1.8%+0.9%+2.5%
3M+2.7%-26.5%+29.2%+5.1%
6M+3.3%-31.1%+34.4%+6.2%
YTD+6.5%-24.1%+30.6%+8.3%
1Y+10.7%-30.2%+40.8%+13.4%
3Y+64.4%+37.0%+27.4%+53.9%
5Y+46.7%+19.9%+26.8%+35.9%
10Y+109.4%+238.5%-129.2%+61.3%
All+270.5%+6,717.5%-6,447.0%+115.0%

Cumulative growth

Daily Returns

Daily percentage return beside DKS.

Daily Out/Under-Performance

Portfolio return minus DKS return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × DKS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded DKS wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling